HKSE · 6639.HK
Arrail Group Limited
HK$1.83+HK$0.08 (+4.57%)
Arrail Group Limited’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
Loading market information…
HKSE · 3869.HK · HKD
Stock price, earnings
Quote as of Sep 21, 2026, 03:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Hospital Corporation of China Limited’s quoted price sits in the lower half of its reported 52-week range, 50.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hospital Corporation of China Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hospital Corporation of China Limited, an investment holding enterprise, primarily focuses on the administration and direct management of hospitals across the People's Republic of China. The company extends specialized management and consulting services to institutions like Yangsi Hospital, Cixi Hospital, and Jinhua Hospital, alongside providing comprehensive general medical care. Additionally, the firm is active in the wholesale distribution of pharmaceutical products. Established in 2014, Hospital Corporation of China Limited maintains its corporate headquarters in Beijing, PRC, and functions as a subsidiary of Vanguard Glory Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.83+HK$0.08 (+4.57%)
Arrail Group Limited’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
HK$1.56-HK$0.06 (-3.7%)
Honliv Healthcare Management Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 10.86% below the high.
HK$11.54+HK$0.54 (+4.91%)
Wenzhou Kangning Hospital Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.37% below the high.
HK$0.79-HK$0.11 (-12.29%)
Tian An Medicare Limited’s quoted price sits in the lower half of its reported 52-week range, 42.28% below the high.
HK$1.77-HK$0.01 (-0.56%)
CANbridge Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.43% below the high.
HK$2.20HK$0.00 (0.0%)
EuroEyes International Eye Clinic Limited’s quoted price sits in the lower half of its reported 52-week range, 34.33% below the high.
HK$1.37-HK$0.07 (-4.86%)
Kintor Pharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 70.85% below the high.
HK$1.74+HK$0.06 (+3.57%)
Guangdong Kanghua Healthcare Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
